ASCO 2022 – Carvykti casts a long shadow

ASCO 2022 – Carvykti casts a long shadow

Source: 
EP Vantage
snippet: 

Arcellx, Gracell and Oricell work hard to prove that there is still space for new Car-T therapies in multiple myeloma.